-
1
-
-
84908173579
-
Ovarian cancer
-
24767708 Epub 2014/04/29
-
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384(9951):1376-88. Epub 2014/04/29. doi: 10.1016/S0140-6736 (13) 62146-7 PMID: 24767708.
-
(2014)
Lancet.
, vol.384
, Issue.9951
, pp. 1376-1388
-
-
Jayson, G.C.1
Kohn, E.C.2
Kitchener, H.C.3
Ledermann, J.A.4
-
2
-
-
84864918124
-
Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine
-
22898329 Epub 2012/08/18, PubMed Central PMCID: PMC3477050
-
Stamelos VA, Redman CW, Richardson A. Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine. J Mol Signal. 2012;7(1):12. Epub 2012/08/18. doi: 10.1186/1750-2187-7-12 PMID: 22898329; PubMed Central PMCID: PMC3477050.
-
(2012)
J Mol Signal.
, vol.7
, Issue.1
, pp. 12
-
-
Stamelos, V.A.1
Redman, C.W.2
Richardson, A.3
-
3
-
-
37249003222
-
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
-
18056200 Epub 2007/12/07
-
Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, et al. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. Clin Cancer Res. 2007;13(23):7191-8. Epub 2007/12/07. doi: 10.1158/1078-0432. CCR-07-0362 PMID: 18056200.
-
(2007)
Clin Cancer Res.
, vol.13
, Issue.23
, pp. 7191-7198
-
-
Witham, J.1
Valenti, M.R.2
De-Haven-Brandon, A.K.3
Vidot, S.4
Eccles, S.A.5
Kaye, S.B.6
-
4
-
-
84872837242
-
Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells
-
23168176 Epub 2012/11/22
-
Stamelos VA, Robinson E, Redman CW, Richardson A. Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells. Gynecol Oncol. 2013;128(2):377-82. Epub 2012/11/22. doi: 10.1016/j.ygyno. 2012.11.019 PMID: 23168176.
-
(2013)
Gynecol Oncol.
, vol.128
, Issue.2
, pp. 377-382
-
-
Stamelos, V.A.1
Robinson, E.2
Redman, C.W.3
Richardson, A.4
-
5
-
-
37649023004
-
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
-
18040043 Epub 2007/11/28, PubMed Central PMCID: PMC2148320
-
Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, Murthy Madiraju SR, et al. Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA. 2007;104(49):19512-7. Epub 2007/11/28. doi: 10.1073/pnas.0709443104 PMID: 18040043; PubMed Central PMCID: PMC2148320.
-
(2007)
Proc Natl Acad Sci USA.
, vol.104
, Issue.49
, pp. 19512-19517
-
-
Nguyen, M.1
Marcellus, R.C.2
Roulston, A.3
Watson, M.4
Serfass, L.5
Murthy Madiraju, S.R.6
-
6
-
-
84876260453
-
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies
-
23515850 Epub 2013/03/22, PubMed Central PMCID: PMC3601645
-
Goard CA, Schimmer AD. An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies. Core Evid. 2013;8:15-26. Epub 2013/03/22. doi: 10.2147/CE. S42568 PMID: 23515850; PubMed Central PMCID: PMC3601645.
-
(2013)
Core Evid.
, vol.8
, pp. 15-26
-
-
Goard, C.A.1
Schimmer, A.D.2
-
7
-
-
84961812721
-
-
www.clinicaltrials.gov
-
www.clinicaltrials.gov. Available from: www.clinicaltrials.gov.
-
-
-
-
8
-
-
44849133234
-
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
-
18451169 Epub 2008/05/03, PubMed Central PMCID: PMC4096127
-
Konopleva M, Watt J, Contractor R, Tsao T, Harris D, Estrov Z, et al. Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax). Cancer Res. 2008;68(9):3413-20. Epub 2008/05/03. doi: 10.1158/0008-5472. CAN-07-1919 PMID: 18451169; PubMed Central PMCID: PMC4096127.
-
(2008)
Cancer Res.
, vol.68
, Issue.9
, pp. 3413-3420
-
-
Konopleva, M.1
Watt, J.2
Contractor, R.3
Tsao, T.4
Harris, D.5
Estrov, Z.6
-
9
-
-
77950231711
-
A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells
-
20160031 Epub 2010/02/18, PubMed Central PMCID: PMC2831099
-
Smoot RL, Blechacz BR, Werneburg NW, Bronk SF, Sinicrope FA, Sirica AE, et al. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells. Cancer Res. 2010;70(5):1960-9. Epub 2010/02/18. doi: 10.1158/0008-5472CAN-09-3535 PMID: 20160031; PubMed Central PMCID: PMC2831099.
-
(2010)
Cancer Res.
, vol.70
, Issue.5
, pp. 1960-1969
-
-
Smoot, R.L.1
Blechacz, B.R.2
Werneburg, N.W.3
Bronk, S.F.4
Sinicrope, F.A.5
Sirica, A.E.6
-
10
-
-
79959774131
-
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK
-
21368880 Epub 2010/01/01, PubMed Central PMCID: PMC3032298
-
McCoy F, Hurwitz J, McTavish N, Paul I, Barnes C, O'Hagan B, et al. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis. 2010;1:e108. Epub 2010/01/01. doi: 10.1038/cddis.2010.86 PMID: 21368880; PubMed Central PMCID: PMC3032298.
-
(2010)
Cell Death Dis.
, vol.1
, pp. e108
-
-
McCoy, F.1
Hurwitz, J.2
McTavish, N.3
Paul, I.4
Barnes, C.5
O'Hagan, B.6
-
11
-
-
84906994522
-
Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells
-
25192188 Epub 2014/09/06, PubMed Central PMCID: PMC4156353
-
Koehler BC, Scherr AL, Lorenz S, Elssner C, Kautz N, Welte S, et al. Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells. PLoS One. 2014;9(9):e106571. Epub 2014/09/06. doi: 10.1371/journal.pone.0106571 PMID: 25192188; PubMed Central PMCID: PMC4156353.
-
(2014)
PLoS One.
, vol.9
, Issue.9
, pp. e106571
-
-
Koehler, B.C.1
Scherr, A.L.2
Lorenz, S.3
Elssner, C.4
Kautz, N.5
Welte, S.6
-
12
-
-
84904438962
-
Obatoclax induces G1/G0-phase arrest via p38/p21 (waf1/Cip1) signaling pathway in human esophageal cancer cells
-
24788582 Epub 2014/05/03
-
Zhong D, Gu C, Shi L, Xun T, Li X, Liu S, et al. Obatoclax induces G1/G0-phase arrest via p38/p21 (waf1/Cip1) signaling pathway in human esophageal cancer cells. J Cell Biochem. 2014;115(9):1624-35. Epub 2014/05/03. doi: 10.1002/jcb.24829 PMID: 24788582.
-
(2014)
J Cell Biochem.
, vol.115
, Issue.9
, pp. 1624-1635
-
-
Zhong, D.1
Gu, C.2
Shi, L.3
Xun, T.4
Li, X.5
Liu, S.6
-
13
-
-
84878254063
-
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia
-
23393050 Epub 2013/02/09, PubMed Central PMCID: PMC3617634
-
Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, et al. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood. 2013;121(14):2689-703. Epub 2013/02/09. doi: 10.1182/blood-2012-04-425033 PMID: 23393050; PubMed Central PMCID: PMC3617634.
-
(2013)
Blood
, vol.121
, Issue.14
, pp. 2689-2703
-
-
Urtishak, K.A.1
Edwards, A.Y.2
Wang, L.S.3
Hudome, A.4
Robinson, B.W.5
Barrett, J.S.6
-
14
-
-
84864882707
-
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors
-
22825469 Epub 2012/07/25, PubMed Central PMCID: PMC3406591
-
Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, et al. Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis. 2012;3:e351. Epub 2012/07/25. doi: 10.1038/cddis.2012.92 PMID: 22825469; PubMed Central PMCID: PMC3406591.
-
(2012)
Cell Death Dis.
, vol.3
, pp. e351
-
-
Petrini, I.1
Meltzer, P.S.2
Zucali, P.A.3
Luo, J.4
Lee, C.5
Santoro, A.6
-
15
-
-
82955222366
-
Synthetic prodiginine obatoclax (GX15-070) and related analogues: Anion binding, transmembrane transport, and cytotoxicity properties
-
22069220 Epub 2011/11/10
-
Diazde Grenu B, Iglesias Hernandez P, Espona M, Quinonero D, Light ME, Torroba T, et al. Synthetic prodiginine obatoclax (GX15-070) and related analogues: anion binding, transmembrane transport, and cytotoxicity properties. Chemistry. 2011;17(50):14074-83. Epub 2011/11/10. doi: 10.1002/chem. 201101547 PMID: 22069220.
-
(2011)
Chemistry
, vol.17
, Issue.50
, pp. 14074-14083
-
-
Diazde Grenu, B.1
Iglesias Hernandez, P.2
Espona, M.3
Quinonero, D.4
Light, M.E.5
Torroba, T.6
-
16
-
-
80051745794
-
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis
-
21822052 Epub 2011/08/09, PubMed Central PMCID: PMC3233494
-
Martinez-Paniagua MA, Baritaki S, Huerta-Yepez S, Ortiz-Navarrete VF, Gonzalez-Bonilla C, Bonavida B, et al. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis. Cell Cycle. 2011;10(16):2792-805. Epub 2011/08/09. PMID: 21822052; PubMed Central PMCID: PMC3233494.
-
(2011)
Cell Cycle.
, vol.10
, Issue.16
, pp. 2792-2805
-
-
Martinez-Paniagua, M.A.1
Baritaki, S.2
Huerta-Yepez, S.3
Ortiz-Navarrete, V.F.4
Gonzalez-Bonilla, C.5
Bonavida, B.6
-
17
-
-
84855802012
-
Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. Obatoclax
-
22155350 Epub 2011/12/14
-
Espona-Fiedler M, Soto-Cerrato V, Hosseini A, Lizcano JM, Guallar V, Quesada R, et al. Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax. Biochem Pharmacol. 2012;83(4):489-96. Epub 2011/12/14. doi: 10.1016/j.bcp. 2011.11.027 PMID: 22155350.
-
(2012)
Biochem Pharmacol.
, vol.83
, Issue.4
, pp. 489-496
-
-
Espona-Fiedler, M.1
Soto-Cerrato, V.2
Hosseini, A.3
Lizcano, J.M.4
Guallar, V.5
Quesada, R.6
-
18
-
-
84927692511
-
Obatoclax induces Beclin 1- and ATG5-dependent apoptosis and autophagy in adenoid cystic carcinoma cells
-
25482163 Epub 2014/12/09
-
Liang LZ, Ma B, Liang YJ, Liu HC, Zhang TH, Zheng GS, et al. Obatoclax induces Beclin 1- and ATG5-dependent apoptosis and autophagy in adenoid cystic carcinoma cells. Oral Dis. 2015;21(4):470-7. Epub 2014/12/09. doi: 10.1111/odi.12305 PMID: 25482163.
-
(2015)
Oral Dis.
, vol.21
, Issue.4
, pp. 470-477
-
-
Liang, L.Z.1
Ma, B.2
Liang, Y.J.3
Liu, H.C.4
Zhang, T.H.5
Zheng, G.S.6
-
19
-
-
84914703122
-
Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells
-
25333301 Epub 2014/10/22
-
Wang G, Chen S, Edwards H, Cui X, Cui L, Ge Y. Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells. Oncol Rep. 2014;32(6):2789-94. Epub 2014/10/22. doi: 10.3892/or.2014.3525 PMID: 25333301.
-
(2014)
Oncol Rep.
, vol.32
, Issue.6
, pp. 2789-2794
-
-
Wang, G.1
Chen, S.2
Edwards, H.3
Cui, X.4
Cui, L.5
Ge, Y.6
-
20
-
-
84900503589
-
Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer
-
24534203 Epub 2014/02/19
-
Chen S, Wang G, Niu X, Zhao J, Tan W, Wang H, et al. Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer. Cancer Lett. 2014;348(1-2):20-8. Epub 2014/02/19. doi: 10.1016/j.canlet.2014.02.010 PMID: 24534203.
-
(2014)
Cancer Lett.
, vol.348
, Issue.1-2
, pp. 20-28
-
-
Chen, S.1
Wang, G.2
Niu, X.3
Zhao, J.4
Tan, W.5
Wang, H.6
-
21
-
-
84891826874
-
Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells
-
24216166 Epub 2013/11/13, PubMed Central PMCID: PMC3944051
-
Yazbeck VY, Li C, Grandis JR, Zang Y, Johnson DE. Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells. Oral Oncol. 2014;50(2):120-7. Epub 2013/11/13. doi: 10.1016/j.oraloncology.2013.10.013 PMID: 24216166; PubMed Central PMCID: PMC3944051.
-
(2014)
Oral Oncol.
, vol.50
, Issue.2
, pp. 120-127
-
-
Yazbeck, V.Y.1
Li, C.2
Grandis, J.R.3
Zang, Y.4
Johnson, D.E.5
-
22
-
-
84874317892
-
BH3-mimeticsand cisplatin-induced cell death proceeds through different pathways depending on the availability of death-related cellular components
-
23437261 Epub 2013/02/26, PubMed Central PMCID: PMC3578861
-
Andreu-Fernandez V, Genoves A, Messeguer A, Orzaez M, Sancho M, Perez-Paya E. BH3-mimeticsand cisplatin-induced cell death proceeds through different pathways depending on the availability of death-related cellular components. PLoSOne. 2013;8(2):e56881. Epub 2013/02/26. doi: 10.1371/journal.pone.0056881 PMID: 23437261; PubMed Central PMCID: PMC3578861.
-
(2013)
PLoSOne.
, vol.8
, Issue.2
, pp. e56881
-
-
Andreu-Fernandez, V.1
Genoves, A.2
Messeguer, A.3
Orzaez, M.4
Sancho, M.5
Perez-Paya, E.6
-
23
-
-
79955745789
-
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas
-
21492126 Epub 2011/04/16, PubMed Central PMCID: PMC3092002
-
Brem EA, Thudium K, Khubchandani S, Tsai PC, Olejniczak SH, Bhat S, et al. Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas. Br J Haematol. 2011;153(5):599-611. Epub 2011/04/16. doi: 10.1111/j.1365-2141.2011.08669.x PMID: 21492126; PubMed Central PMCID: PMC3092002.
-
(2011)
Br J Haematol.
, vol.153
, Issue.5
, pp. 599-611
-
-
Brem, E.A.1
Thudium, K.2
Khubchandani, S.3
Tsai, P.C.4
Olejniczak, S.H.5
Bhat, S.6
-
24
-
-
79958276489
-
GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
-
21364679 Epub 2011/03/03, PubMed Central PMCID: PMC3032343
-
Heidari N, Hicks MA, Harada H. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy. Cell Death Dis. 2010;1:e76. Epub 2011/03/03. doi: 10.1038/cddis.2010.53 PMID: 21364679; PubMed Central PMCID: PMC3032343.
-
(2010)
Cell Death Dis.
, vol.1
, pp. e76
-
-
Heidari, N.1
Hicks, M.A.2
Harada, H.3
-
25
-
-
77951171023
-
Induction of autophagydependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
-
20200450 000276258100039
-
Bonapace L, Bornhauser BC, Schmitz M, Cario G, Ziegler U, Niggli FK, et al. Induction of autophagydependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest. 2010;120(4):1310-23. doi: 10.1172/Jci39987. ISI:000276258100039. PMID: 20200450
-
(2010)
J Clin Invest.
, vol.120
, Issue.4
, pp. 1310-1323
-
-
Bonapace, L.1
Bornhauser, B.C.2
Schmitz, M.3
Cario, G.4
Ziegler, U.5
Niggli, F.K.6
-
26
-
-
84869757978
-
Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress
-
22989520 Epub 2012/09/20, PubMed Central PMCID: PMC3502625
-
Cruickshanks N, Tang Y, Booth L, Hamed H, Grant S, Dent P. Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress. Mol Pharmacol. 2012;82(6):1217-29. Epub 2012/09/20. doi: 10.1124/mol.112.081539 PMID: 22989520; PubMed Central PMCID: PMC3502625.
-
(2012)
Mol Pharmacol.
, vol.82
, Issue.6
, pp. 1217-1229
-
-
Cruickshanks, N.1
Tang, Y.2
Booth, L.3
Hamed, H.4
Grant, S.5
Dent, P.6
-
27
-
-
84858788427
-
Obatoclax and lapatinib interact to induce toxic autophagy through NOXA
-
22219388 Epub 2012/01/06, PubMed Central PMCID: PMC3310419
-
Tang Y, Hamed HA, Cruickshanks N, Fisher PB, Grant S, Dent P. Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol. 2012;81(4):527-40. Epub 2012/01/06. doi: 10. 1124/mol.111.076851 PMID: 22219388; PubMed Central PMCID: PMC3310419.
-
(2012)
Mol Pharmacol.
, vol.81
, Issue.4
, pp. 527-540
-
-
Tang, Y.1
Hamed, H.A.2
Cruickshanks, N.3
Fisher, P.B.4
Grant, S.5
Dent, P.6
-
28
-
-
73549101691
-
Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy
-
19823038 Epub 2009/10/14, PubMed Central PMCID: PMC3887451
-
Martin AP, Mitchell C, Rahmani M, Nephew KP, Grant S, Dent P. Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther. 2009;8(21):2084-96. Epub 2009/10/14. PMID: 19823038; PubMed Central PMCID: PMC3887451.
-
(2009)
Cancer Biol Ther.
, vol.8
, Issue.21
, pp. 2084-2096
-
-
Martin, A.P.1
Mitchell, C.2
Rahmani, M.3
Nephew, K.P.4
Grant, S.5
Dent, P.6
-
29
-
-
84882281344
-
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes
-
23744296 Epub 2013/06/08, PubMed Central PMCID: PMC3741498
-
Basit F, Cristofanon S, Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ. 2013;20(9):1161-73. Epub 2013/06/08. doi: 10.1038/cdd.2013.45 PMID: 23744296; PubMed Central PMCID: PMC3741498.
-
(2013)
Cell Death Differ.
, vol.20
, Issue.9
, pp. 1161-1173
-
-
Basit, F.1
Cristofanon, S.2
Fulda, S.3
-
30
-
-
84876492939
-
GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogenresistant breast cancer cells
-
23395885 Epub 2013/02/12, PubMed Central PMCID: PMC3624027
-
Schwartz-Roberts JL, Shajahan AN, Cook KL, Warri A, Abu-Asab M, Clarke R. GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogenresistant breast cancer cells. Mol Cancer Ther. 2013;12(4):448-59. Epub 2013/02/12. doi: 10.1158/1535-7163. MCT-12-0617 PMID: 23395885; PubMed Central PMCID: PMC3624027.
-
(2013)
Mol Cancer Ther.
, vol.12
, Issue.4
, pp. 448-459
-
-
Schwartz-Roberts, J.L.1
Shajahan, A.N.2
Cook, K.L.3
Warri, A.4
Abu-Asab, M.5
Clarke, R.6
-
31
-
-
84943199868
-
Cell death by autophagy: Emerging molecular mechanisms and implications for cancer therapy
-
25619832 Epub 2015/01/27
-
Fulda S, Kogel D. Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene. 2015. Epub 2015/01/27. doi: 10.1038/onc.2014.458 PMID: 25619832.
-
(2015)
Oncogene.
-
-
Fulda, S.1
Kogel, D.2
-
32
-
-
76549129820
-
Drug combination studies and their synergy quantification using the Chou-Talalay method
-
20068163 Epub 2010/01/14
-
Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440-6. Epub 2010/01/14. doi: 10.1158/0008-5472. CAN-09-1947 PMID: 20068163.
-
(2010)
Cancer Res.
, vol.70
, Issue.2
, pp. 440-446
-
-
Chou, T.C.1
-
33
-
-
77949915910
-
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
-
20100569 Epub 2010/01/27
-
Vidot S, Witham J, Agarwal R, Greenhough S, Bamrah HS, Tigyi GJ, et al. Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. Cell Signal. 2010;22(6):926-35. Epub 2010/01/27. doi: 10.1016/j.cellsig.2010.01.017 PMID: 20100569.
-
(2010)
Cell Signal.
, vol.22
, Issue.6
, pp. 926-935
-
-
Vidot, S.1
Witham, J.2
Agarwal, R.3
Greenhough, S.4
Bamrah, H.S.5
Tigyi, G.J.6
-
34
-
-
0030694182
-
Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: A role for paxillin tyrosine phosphorylation
-
9372922 Epub 1997/12/31, PubMed Central PMCID: PMC232547
-
Richardson A, Malik RK, Hildebrand JD, Parsons JT. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol. 1997;17(12):6906-14. Epub 1997/12/31. PMID: 9372922; PubMed Central PMCID: PMC232547.
-
(1997)
Mol Cell Biol.
, vol.17
, Issue.12
, pp. 6906-6914
-
-
Richardson, A.1
Malik, R.K.2
Hildebrand, J.D.3
Parsons, J.T.4
-
35
-
-
34047228186
-
Microplate assay for quantitative determination of cathepsin activities in viable cells using derivatives of 4-methoxy-beta-naphthylamide
-
17068963 Epub 2006/10/31
-
Ruttger A, Mollenhauer J, Loser R, Gutschow M, Wiederanders B. Microplate assay for quantitative determination of cathepsin activities in viable cells using derivatives of 4-methoxy-beta-naphthylamide. Biotechniques. 2006;41(4):469-73. Epub 2006/10/31. PMID: 17068963.
-
(2006)
Biotechniques.
, vol.41
, Issue.4
, pp. 469-473
-
-
Ruttger, A.1
Mollenhauer, J.2
Loser, R.3
Gutschow, M.4
Wiederanders, B.5
-
36
-
-
71749096160
-
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
-
19836374 000272748300025
-
Solomon VR, Lee H. Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol. 2009;625(1-3):220-33. doi: 10.1016/j.ejphar.2009.06.063. ISI:000272748300025. PMID: 19836374
-
(2009)
Eur J Pharmacol.
, vol.625
, Issue.1-3
, pp. 220-233
-
-
Solomon, V.R.1
Lee, H.2
-
37
-
-
79961238238
-
Antimalarial activity of natural and synthetic prodiginines
-
21736388 Epub 2011/07/09, PubMed Central PMCID: PMC4494750
-
Papireddy K, Smilkstein M, Kelly JX, Shweta, Salem SM, Alhamadsheh M, et al. Antimalarial activity of natural and synthetic prodiginines. J MedChem. 2011;54(15):5296-306. Epub 2011/07/09. doi: 10. 1021/jm200543y PMID: 21736388; PubMed Central PMCID: PMC4494750.
-
(2011)
J MedChem.
, vol.54
, Issue.15
, pp. 5296-5306
-
-
Papireddy, K.1
Smilkstein, M.2
Kelly, J.X.3
Shweta4
Salem, S.M.5
Alhamadsheh, M.6
-
38
-
-
44849107047
-
The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes
-
18449189 Epub 2008/05/02
-
Graves AR, Curran PK, Smith CL, Mindell JA. The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature. 2008;453(7196):788-92. Epub 2008/05/02. doi: 10.1038/nature06907 PMID: 18449189.
-
(2008)
Nature.
, vol.453
, Issue.7196
, pp. 788-792
-
-
Graves, A.R.1
Curran, P.K.2
Smith, C.L.3
Mindell, J.A.4
-
39
-
-
84872288221
-
Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition
-
23168408 Epub 2012/11/22, PubMed Central PMCID: PMC3543021
-
Von Schwarzenberg K, Wiedmann RM, Oak P, Schulz S, Zischka H, Wanner G, et al. Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J Biol Chem. 2013;288(2):1385-96. Epub 2012/11/22. doi: 10.1074/jbc. M112.412007 PMID: 23168408; PubMed Central PMCID: PMC3543021.
-
(2013)
J Biol Chem.
, vol.288
, Issue.2
, pp. 1385-1396
-
-
Von Schwarzenberg, K.1
Wiedmann, R.M.2
Oak, P.3
Schulz, S.4
Zischka, H.5
Wanner, G.6
-
40
-
-
19944434059
-
Inhibition of macroautophagy triggers apoptosis
-
Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25(3):1025-40.
-
(2005)
Mol Cell Biol.
, vol.25
, Issue.3
, pp. 1025-1040
-
-
Boya, P.1
Gonzalez-Polo, R.A.2
Casares, N.3
Perfettini, J.L.4
Dessen, P.5
Larochette, N.6
-
41
-
-
84906043176
-
Targeting SQSTM1/p62 induces cargo loading failure and converts autophagyto apoptosis via NBK/Bik
-
25002530 Epub 2014/07/09, PubMed Central PMCID: PMC4135623
-
Chen S, Zhou L, Zhang Y, Leng Y, Pei XY, Lin H, et al. Targeting SQSTM1/p62 induces cargo loading failure and converts autophagyto apoptosis via NBK/Bik. Mol Cell Biol. 2014;34(18):3435-49. Epub 2014/07/09. doi: 10.1128/MCB.01383-13 PMID: 25002530; PubMed Central PMCID: PMC4135623.
-
(2014)
Mol Cell Biol.
, vol.34
, Issue.18
, pp. 3435-3449
-
-
Chen, S.1
Zhou, L.2
Zhang, Y.3
Leng, Y.4
Pei, X.Y.5
Lin, H.6
-
42
-
-
84860331447
-
A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation
-
22465052 Epub 2012/04/03
-
Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, et al. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Lett. 2012;321(1):27-35. Epub 2012/04/03. doi: 10.1016/j.canlet.2012.03.023 PMID: 22465052.
-
(2012)
Cancer Lett.
, vol.321
, Issue.1
, pp. 27-35
-
-
Chen, K.F.1
Su, J.C.2
Liu, C.Y.3
Huang, J.W.4
Chen, K.C.5
Chen, W.L.6
-
43
-
-
84859939822
-
Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XLand MCL-1
-
22357666 Epub 2012/02/24, PubMed Central PMCID: PMC3336802
-
Cruickshanks N, Hamed HA, Bareford MD, Poklepovic A, Fisher PB, Grant S, et al. Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XLand MCL-1. Mol Pharmacol. 2012;81(5):748-58. Epub 2012/02/24. doi: 10.1124/mol.112.077586 PMID: 22357666; PubMed Central PMCID: PMC3336802.
-
(2012)
Mol Pharmacol.
, vol.81
, Issue.5
, pp. 748-758
-
-
Cruickshanks, N.1
Hamed, H.A.2
Bareford, M.D.3
Poklepovic, A.4
Fisher, P.B.5
Grant, S.6
-
44
-
-
84876070821
-
BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
-
22230093 Epub 2012/01/11, PubMed Central PMCID: PMC3770266
-
Del Gaizo Moore V, Letai A. BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 2013;332(2):202-5. Epub 2012/01/11. doi: 10. 1016/j.canlet.2011.12.021 PMID: 22230093; PubMed Central PMCID: PMC3770266.
-
(2013)
Cancer Lett.
, vol.332
, Issue.2
, pp. 202-205
-
-
Del Gaizo Moore, V.1
Letai, A.2
|